UC San Diego School of Medicine is developing an AI to predict opioid addiction risk, funded by Wellcome Leap's "Untangling and Addiction" program, using EHR and genomic data to prevent addiction.

Takeda Pharmaceutical closes its San Diego research center, impacting 324 workers who face relocation or layoffs amid company restructuring focused on late-stage drug development.

i-NETT announces a new IT program to help protect nonprofits in San Diego from cybercrime and doxing. The initiative includes Microsoft products, PR advice, and assistance with donation solicitation, all free of charge.

UC San Diego Health integrates AI into its Epic Systems electronic health record to handle patient messages, easing doctors' cognitive load without reducing response times.

Agilent Technologies and UC San Diego have partnered to establish a Center of Excellence focused on Cellular Intelligence within UC San Diego's School of Medicine to advance research on cellular behavior.

Artemis II astronauts joined the USS San Diego crew and Navy divers for a recovery drill, part of preparations for the first crewed moon mission in over 50 years.

SDG&E unveils four advanced microgrids in San Diego that enhance grid resilience and utilize remote management to maintain power during outages and peak demand times.

Engineers from San Diego State University and USC design 3D-printed protective gear inspired by cuttlefish bones for athletes, service members, and astronauts.

The University of California San Diego developed an AI tool, COMPOSER, that successfully predicts sepsis, leading to a 17% reduction in related mortality rates.

Atmospheric chemist Kimberly Prather from UC San Diego wins the 2024 NAS Award in Chemical Sciences for her work on atmospheric aerosols' effects on climate, air quality, and health.

UC San Diego scientists developed an AI that predicts tumor responses to chemotherapy, potentially improving cervical cancer treatment by assessing genetic mutations en masse.

Limmi has launched an AI-powered Disease Insights Platform to improve early disease detection and management, initially focusing on predicting kidney stone recurrence in collaboration with UC San Diego Health.

Scientists at UC San Diego have created a noninvasive test to improve IVF, analyzing exRNAs in embryos' culture media to identify quality embryos, potentially increasing success rates.